Cheap Imports Are Making America Poorer
Cheap imports shaved prices on some goods but never made Americans richer. Wage losses and job destruction outweighed any discounts.
Defense Production Act to Be Part of Re-Industrialization Strategy, House Armed Services Hearing Confirms
On Capitol Hill, the defense narrative clearly gets legislators’ attention. It remains the surest way to get Members of Congress thinking about reindustrialization and rebuilding domestic supply chains.
Why 2025’s Record Breaking Trade Deficit Doesn’t Hurt the Argument for Tariffs
It was no surprise that the 2025 goods deficit broke another record, the Bureau of Economic Analysis (BEA) numbers showed recently. The year-ending goods deficit was $1.24 trillion, up from $1.21 trillion in 2024, with the monthly deficit for December looking like historic averages, nearly $100 billion. Nothing seems to stop America’s appetite for imports.
CPA Applauds Trump Administration’s Consideration of New Section 232 National Security Tariffs
CPA urges the administration to move swiftly to deploy Section 232 investigations through the U.S. Department of Commerce as the most durable and effective tool available to restore American industrial capacity.
An Industrial Policy Success Story Trump Should Champion: The Manufacturing Extension Partnership
President Trump has made American reindustrialization and reshoring central to his economic policy agenda. Reviving American manufacturing enjoys broad public support and has increasingly become a bipartisan priority.
Senate Finance Hearing: Pro-USMCA and Decisively Anti-Tariff on Mexico and Canada
The Senate Finance Committee agrees on two things: First, the U.S. Mexico and Canada Agreement (USMCA) isn’t perfect and a number of issues need fixing. Second, they don’t want tariffs.
CPA Applauds Cassidy, Whitehouse Bill to Close Customs Loophole, Strengthen American Manufacturers
CPA strongly supports Senator Cassidy and Whitehouse’s Last Sale Valuation Act because it closes a long-standing loophole that has allowed multinational importers to artificially understate the value of goods entering the United States.
CPA Applauds Administration’s Recognition of Pharmaceuticals Import Risk in India Interim Agreement
This Interim Agreement framework reflects a long overdue acknowledgment that essential medicine supply chains cannot be left to foreign dominance, particularly by India or an adversary like China.
Import Alert: India Drug Maker Recalls Cholesterol Meds Due To Manufacturing Defects
Zydus Pharmaceuticals, one of India’s largest generic drug makers, recalled over 22,000 bottles of a cholesterol medication on Dec. 30, 2025. AvKare, a Tennessee-based pharmaceuticals distribution company that relies on imports, recalled around 7,900 cartons of Rosuvastatin, a widely used generic statin, a day later.
CPA Applauds Clarios, Responsible Battery Coalition Member Company, for Leadership in Sustainable, Secure Battery Supply Chains
As highlighted in the Oval Office at the White House this week, Clarios played a part in the launch of ‘Project Vault,’ a major initiative to strengthen U.S. critical minerals security and safeguard American battery supply chains from global disruptions.
